Read + Share
Oh DY, Algazi A, Capdevila J, Longo F, et al. Efficacy and safety of pembrolizumab monotherapy in patients with advanced
thyroid cancer in the phase 2 KEYNOTE-158 study. Cancer 2023 Feb 7. doi: 10.1002/cncr.34657.
PMID: 36748723
|
 |
|
Oh DY, Algazi A, Capdevila J, Longo F, et al. Efficacy and safety of pembrolizumab monotherapy in patients with advanced
thyroid cancer in the phase 2 KEYNOTE-158 study. Cancer 2023 Feb 7. doi: 10.1002/cncr.34657.
PMID: 36748723
|
|
|
|